Search Results

Displaying Results 1-1 of 1 "'IMRX'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

Dec 12, 2025, 10:47 ET Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

harsh tumor environments[2]. These advances position Oncolytics Biotech Inc. (NASDAQ: ONCY), Immuneering Corporation (NASDAQ: IMRX), Tango Therapeutics, Inc. (NASDAQ: TNGX), Moderna, Inc. (NASDAQ: MRNA), and Royalty Pharma plc (NASDAQ: RPRX) as companies advancing

More news about: USA News Group

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.